Yahoo Web Search

Search results

  1. I am passionate about using design to solve real-world problems and believe education is the key to unlocking human potential, whether by analysing it or providing it. I am Prajakta, an...

    • 500+
    • Convo Research & Strategy Private Limited
    • Maeer's MIT Institute of Design
  2. Hypoxia responsive, tumor penetrating lipid nanoparticles for delivery of chemotherapeutics to pancreatic cancer cell spheroids. P Kulkarni, MK Haldar, P Katti, C Dawes, S You, Y Choi, S Mallik....

  3. Prajakta Kulkarni is a software engineer in Microsofts Applied Sciences Group (ASG) working on next-generation user experiences and incubation projects.

    • Personal Life
    • Career
    • External Links

    Prajakta was born in Dadar, Mumbai. She completed her schooling from Balmohan Vidyamandir. She is married to Rajan Dighe who is a Interior designer. They have one son Jay Dighe who is a Bollywood Photographer and choreographer.

    Prajakta Kulkarni became a household name after she tasted success with her work in movies such as Dhadakebaj and Char Divas sasuche which firmed her position in Marathi films and continued to work with actors such as Ashok Saraf and Laxmikant Berde. She made her debut in the movie Damini and Aag in the 90s and later continued her stint in Hindi Ci...

    • Dadar , Mumbai , India
    • Rajan Dighe ( m. 1992)
  4. Location: Singapore, Singapore · 500+ connections on LinkedIn. View Prajakta Kulkarnis profile on LinkedIn, a professional community of 1 billion members.

    • 500+
    • 808
  5. Overview. I have a long-term research interest in investigating autophagy pathways and organelle dynamics in a variety of physiological processes and disease models, and to exploit this knowledge for the design of new therapeutics.

  6. Researcher biography. I have a long-term research interest in investigating autophagy pathways and organelle dynamics in a variety of physiological processes and disease models, and to exploit this knowledge for the design of new therapeutics.